Effects of AZT and RNA-protein complex (FA-2-b-beta) extracted from Liang Jin mushroom on apoptosis of gastric cancer cells.
OBJECTIVE
To investigate the synergistic effects of 3'-azido-3'-deoxythymidine (AZT) and FA-2-b-beta extracted from Ling Jin mushroom on apoptosis of gastric cancer cells MKN45 in vitro.


METHODS
MTT analysis was made to examine the inhibition rate of MKN45 cells treated with AZT (2.5, 5, 10 and 20 mg/L) and FA-2-b-beta (5, 10, 20 and 40 mg/L) singly and combinatively for 24, 48 and 72 h. Apoptotic effects were evaluated by morphological methods, DNA agarose gel electrophoresis and flow cytometry, respectively. Telomerase activity was estimated by TRAP-ELISA. The mRNA expression of caspase-3 and Bcl-2 were detected by RT-PCR.


RESULTS
AZT and FA-2-b-beta could significantly inhibit MKN45 cell proliferation and induce its apoptosis. MKN45 cells were inhibited in dose- and time- dependent manner. The inhibition effect of AZT combined with FA-2-b-beta was obviously better than that used singly (0.469 +/- 0.022 vs 1.075 +/- 0.055, P < 0.05, 0.325 +/- 0.029 vs 0.469 +/- 0.022 P < 0.01). AZT used singly and combination of FA-2-b-beta could decrease the activity of tumor cell telomerase, and AZT has synergistic function with FA-2-b-beta. A certain concentration of AZT could up-regulate the expression of caspase-3 mRNA (r = 0.9969, P < 0.01), which was positively related to apoptosis rate, and could down-regulate the expression of Bcl-2 mRNA, which was negatively related to apoptosis rate (r = 0.926, P < 0.01). Furthermore, the effect of AZT combined with FA-2-b-beta was significantly higher than that used singly.


CONCLUSIONS
Combination of AZT and FA-2-b-beta has an obviously synergetic effect in the gastric cancer cells MKN45, which has provided a new approach to the treatment of gastric cancer clinically.
Sun
Yan-Qing
YQ
School of Life Science, Lanzhou University, Lanzhou 730000, Gansu Province, China.
Guo
Tian-Kang
TK
Xi
Ya-Ming
YM
Chen
Che
C
Wang
Jin
J
Wang
Zi-Ren
ZR
D000363:Agaricales; D017209:Apoptosis / Q000187:drug effects*; D053148:Caspase 3 / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008517:Phytotherapy; D010940:Plant Proteins / Q000494:pharmacology*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D013274:Stomach Neoplasms / Q000473:pathology*; D015215:Zidovudine / Q000494:pharmacology*
D004365:Drugs, Chinese Herbal; D010940:Plant Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D012333:RNA, Messenger; D015215:Zidovudine; D053148:Caspase 3
Cell. 1997 Aug 22;90(4):785-95
9288757
World J Gastroenterol. 2003 Sep;9(9):1930-4
12970878
Carbohydr Res. 1989 Mar 15;186(2):267-73
2736561
J Surg Res. 2006 Apr;131(2):252-5
16427084
Biol Pharm Bull. 2004 Mar;27(3):404-6
14993810
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):10964-7
10500109
Nat Rev Drug Discov. 2006 Jul;5(7):577-84
16773071
Arch Pathol Lab Med. 1998 Apr;122(4):310-9
9648897
Biochem Pharmacol. 1990 Nov 15;40(10):2353-62
2244936
Blood. 2006 Aug 1;108(3):1021-9
16569765
Shock. 2006 Apr;25(4):420-5
16670646
Cancer Res. 2003 Feb 15;63(4):824-30
12591733
Int J Gynecol Cancer. 2004 Jul-Aug;14(4):589-94
15304151
Science. 1994 Dec 23;266(5193):2011-5
7605428
J Biol Chem. 1997 May 30;272(22):14183-7
9162048
Pharmacol Toxicol. 2000 Sep;87(3):138-43
11068855
J Agric Food Chem. 2004 Oct 6;52(20):6330-7
15453709
Biochem Biophys Res Commun. 1998 May 8;246(1):107-10
9600076
J Nutr. 2001 May;131(5):1409-13
11340091
Curr Opin Oncol. 2004 Jan;16(1):32-8
14685090
Leukemia. 2002 Apr;16(4):433-43
11960320
DNA Cell Biol. 2004 Mar;23(3):135-40
15068582
Biosci Biotechnol Biochem. 2005 Dec;69(12):2466-9
16377912
Nature. 1998 Jan 1;391(6662):43-50
9422506
Jpn J Clin Oncol. 1997 Aug;27(4):216-20
9379506
Breast Cancer Res Treat. 2005 Oct;93(3):227-36
16132531
Clin Cancer Res. 1998 Mar;4(3):693-6
9533539
Toxicol In Vitro. 2005 Jun;19(4):533-9
15826811
Cell Struct Funct. 2001 Apr;26(2):103-8
11482452
Biochem Biophys Res Commun. 2007 Mar 9;354(2):351-6
17223082